v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (5,446,255) $ (10,367,061)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 30,268 40,553
Stock-based compensation expense 2,849,592 7,292,701
Non-cash interest expense 24,577
Change in fair value of warrants (25,831) (13,857)
Amortization of right-of-use asset 28,783 64,849
Change in operating assets and liabilities:    
Prepaid expenses and other assets (341,597) (24,968)
Other assets (3)
Accounts payable 458,472 (535,499)
Accrued expenses and other liabilities (258,417) 274,650
Operating lease liabilities (28,781) (64,008)
Net cash used in operating activities (2,733,769) (3,308,063)
Cash flows from investing activities:    
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from loan agreement 2,000,000 2,000,000
Proceeds from issuance of shares under the sales agreement, net of offering costs 873,702
Capital contribution 2,000,000
Net cash provided by financing activities 2,873,702 4,000,000
Net increase in cash 139,933 691,937
Cash - beginning of period 552,372 1,282,995
Cash - end of period 692,305 1,974,932
Supplementary disclosure of noncash investing and financing activities:    
Deferred offering cost amortization 4,168
Receivables from issuance of shares under the sales agreement $ 119,697